The QualityStocks Daily Monday, January 7th, 2019

Today's Top 3 StockMarketWatch

PennyStockProphet (AXSM) +161.22%

Top Pros' Top Picks (LXFT) +81.96%

Penny Stock Titans (AGHI) +53.35%

The QualityStocks Daily Stock List

Tinka Resources Limited (TKRFF)

Hotstocked, Junior Mining Network, Streetwise Reports, Canadian Insider, Wallet Investor, Dividend Investor, The Prospector News, 24hgold, Barchart, Stockhouse, InvestingNews, TradingView, Northern Miner, InvestorsHub, MarketWatch, InvestorsHangout, and OTC Markets reported on Tinka Resources Limited (TKRFF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Tinka Resources Limited is an exploration and development company listed on the OTC Markets. Its flagship property is the 100 percent-owned Ayawilca carbonate replacement deposit (CRD) in the zinc-lead-silver belt of central Peru (200 kilometers northeast of Lima). Tinka Resources owns 100 percent of the contiguous 150 km2 mining concessions at Ayawilca. The Company is focusing on growing the Ayawilca Mineral Resources. Tinka Resources is based in Vancouver, British Columbia.

Three NI 43-101 Mineral Resources exist on the Property. The Zinc Zone and Tin Zone resources are thought to be mineable by underground methods for resource calculation purposes. The Colquipucro Silver Zone is thought to be mineable by open pit methods.

The Ayawilca Zinc Zone Inferred Mineral Resource estimate currently comprises 42.7 Mt at 6.0 % zinc, 0.2 % lead, 17 g/t silver, and 79 g/t indium. It also consists of a Tin Zone Inferred Mineral Resource of 10.5 Mt at 0.63 % tin, 0.23 % copper & 12 g/t silver.

In September, Tinka Resources announced results for twelve drill holes from its continuing resource expansion and confirmation drill program at the Ayawilca project, central Peru. Dr. Graham Carman, President and Chief Executive Officer of Tinka Resources, stated: "The step-out drill hole results reported in this release are very positive, and show that the footprint of zinc mineralization at Ayawilca is getting larger. So far in 2018 we have discovered several new areas of significant zinc mineralization…”

Moreover, in recent months, Tinka Resources provided an update of exploration results at the Ayawilca project, including results for ten recent drill holes. Dr. Graham Carman stated this month, "Tinka has been drilling continuously at Ayawilca for 20 months since February 2017 , having drilled more than 40,000 meters during that time. The Company is now focusing on compiling and analyzing the large quantity of drill hole information, completing a mineral resource update, expanding metallurgical test work, and advancing the project to a PEA in 2019. Tinka is well positioned financially with C$13 million in cash reserves at the end of September 2018 and no debt."

Tinka Resources Limited (TKRFF), closed Monday's trading session at $0.25, down 0.83%, on 14,659 volume with 7 trades. The average volume for the last 3 months is 47,119 and the stock's 52-week low/high is $0.207/$0.625.

chart

Firstgroup plc (FGROY)

Zacks, OTC Research, Amigo Bulls, Proactive Investors, OTC Markets, The Street, Marketbeat, TradingView, Investors Hangout, InvestorPoint, Wallmine, GuruFocus, Investing.com, Penny Stock Tweets, 4-Traders, Stockhouse, Wallet Investor, YCharts, Barchart, Dividend Investor and MoneyHub reported on Firstgroup plc (FGROY), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Incorporated in 1995, Firstgroup plc provides passenger transport services. The Company has extensive experience in the United Kingdom bus and rail markets, and in the student transportation, transit and intercity coach markets in North America. Each of its businesses has a market-leading position in a sector that is key to boosting economic growth and vital to creating strong and sustainable
communities.  Firstgroup lists on the OTC Markets and the Company has its head office in London, England.

Firstgroup serves a large range of passengers in the United Kingdom and North America. In addition, the Company works with national governments, state and local authorities, school boards and universities to meet their transport requirements.

Firstgroup has 100,000 employees across the Group and it carries 2.1 billion passengers a year. The Company operates, manages or maintains combined fleets of 50,000 vehicles. Firstgroup has five divisions.

The Company’s Greyhound is the only national operator of scheduled intercity coach services in North America. Greyhound serves 17 million passengers a year. Greyhound has 1,600 vehicles in its fleet.

Moreover, Firstgroup’s First Bus is one of the largest bus operators in the United Kingdom. First Bus serves towns and cities across the country. First Bus has 5,800 buses and serves 1.6 million passengers per day.

First Rail is one of the United Kingdom’s most experienced rail operators. It runs every kind of service from Cornwall to Scotland. First Rail operates more than 400 stations. It operates three United Kingdom rail franchises - Great Western Railway, South Western Railway and TransPennine Express. It also operates one open access passenger rail service, Hull Trains. Furthermore, it operates the London Trams service on behalf of Transport for London.

The Company’s First Student is the largest provider of student transportation in North America. First Student has greater than 460 operating locations throughout the United States and Canada. It engages in five million student journeys per school day.

The Company’s First Transit is one of the largest private sector providers of public transit management and contracting in North America. First Transit has over 310 operating locations throughout the United States and Canada. It owns or operates greater than 12,600 vehicles and maintains a further 35,000.

Firstgroup plc (FGROY), closed Monday's trading session at $1.24, up 5.98%, on 300 volume with 3 trades. The average volume for the last 3 months is 288 and the stock's 52-week low/high is $1.038/$1.659.

chart

Kutcho Copper Corp. (KCCFF)

InvestorX, Wallet Investor, OTC Markets, Resource Stock Digest, Market Screener, 4-Traders, Stateside Report, Junior Mining Network, Junior Stock Review, Investors Hangout, The Prospector News, Mining & Energy, Stock Orange, Resource World, Dividend Investor, Stockhouse, Stockwatch, MarketWatch, and Barchart reported earlier on Kutcho Copper Corp. (KCCFF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

A resource development company, Kutcho Copper Corp. focuses on expanding and developing the Kutcho high grade copper-zinc project in northern British Columbia. The Company’s intention is to progress the Kutcho Project through feasibility and permitting to a positive construction decision. Kutcho Copper is based in Vancouver, British Columbia (B.C.).

The Kutcho Copper Project is the Company’s 100 percent owned high grade copper-zinc development project in northern B.C. This Project is in a top tier mining jurisdiction with major mines and permitted projects in Tahltan and Kaska territories. Kutcho has a Probable Reserve of 10.4 Mt grading 2.01% Cu and
3.19% Zn (2.92% CuEq).

The Kutcho Copper Project has a Mine Life of 12 years. Its Production Rate is 2,500 tpd. The Project has low risk potential to increase Mineral Reserves
and considerably increase production capacity. The Wheaton Precious Metals stream establishes a foundation for a strong partnership and reduces financial risk of the Project. In addition, there is the potential for more discoveries through exploration. Kutcho Copper’s aim is to boost reserves from the current 10.4 Mt via existing resource conversion.

Kutcho Copper has launched MineHub Technologies, Inc. with a syndicate of industry partners. This includes a senior mining company, one of the world’s largest streaming companies, an international base and precious metals and concentrates trading company and a global financial institution providing banking services in the metals and mining industry. MineHub is a cutting-edge technology company leveraging blockchain technology to develop a new generation of applications for the metals and mining industry.

Last week, Kutcho Copper announced drill results from the Main deposit at its Kutcho high grade copper-zinc project. Highlight intersections from the Main deposit include KC18-261 with 9.9m of 1.29% Cu, 4.1% Zn, 35.1 g/t Ag, 0.34 g/t Au or 3.5% CuEq (including 4.4m of 5.0% CuEq).

Highlight intersections also include KC18-271 with 9.9m of 2.79% Cu, 0.9%Zn, 72.9 g/t Ag, 0.45g/t Au or 4.1% CuEq (including 2.8m of 10.9% CuEq). Additionally, highlight intersections include KC18-285 with 4.9m of 0.87% Cu, 4.3% Zn, 20.6g/t Ag, 0.18g/t Au or 2.89% CuEq (including 2.3m of 5.0% CuEq).

Kutcho Copper Corp. (KCCFF), closed Monday's trading session at $0.23, up 1.06%, on 46,300 volume with 8 trades. The average volume for the last 3 months is 7,803 and the stock's 52-week low/high is $0.143/$0.759.

chart

WEED, Inc. (BUDZ)

Penny Stock Tweets, Market Screener, Wallet Investor, InvestorsHub, Micro Cap Daily, Equities, Barchart, StockInvest, Advanced Equity Research, Green Market Report, TipRanks, The Street, FXStreet, Micro Small Cap, YCharts, 4-Traders, Capital Cube, Street Register, TradingView, Investor Place, Insider Financial, Stockhouse, MarketWatch, and Finance Registrar reported earlier on WEED, Inc. (BUDZ), and we also report on the Company, here at the QualityStocks Daily Newsletter.

WEED, Inc. is a multi-national, multi-faceted, vertically-integrated world class cannabis organization. Its dedication is to its global objectives and outreach across the full spectrum of the cannabis industry to find treatments, therapies as well as medical cures using the Cannabaceae plant family. WEED has established WEED Israel (Cannabis) Ltd. as a wholly-owned subsidiary of WEED, Inc (USA). WEED is based in Tucson, Arizona and the Company lists on the OTCQB.

WEED is structured as a holding company. It does business through its divisions, wholly-owned subsidiaries, and strategically placed collaborative partners to achieve and promote its global brand. WEED does not grow, harvest, produce, or sell any substance in violation of US Federal law under The Federal Controlled Substances Act. In addition, the Company meets all standards of international law for WEED, Inc. and its subsidiaries in foreign locales.

WEED has purchased a 4-acre property in La Veta, Colorado. This is where the Company’s wholly-owned subsidiary, Sangre AgroTech, is engaged in the earlier announced 5-year, $15-plus million Cannabis Genomic Study. In association with the La Veta property, WEED received unanimous approval of the La Veta Town Council for a Commercial Redevelopment Permit to start planned renovations and construction of the Bioscience Research Center for the operations of Sangre AgroTech to convert the existing buildings into laboratory facilities needed for Sangre to conduct its research, along with additional security and ground buildout.

Sangre AT, LLC, dba Sangre AgroTech, has begun a five-year Cannabis Genomic Study to complete a genetic blueprint of the Cannabis plant genus, through creating an international genomic classification of the entire plant. By targeting cannabis-derived molecules that stimulate the endocannabinoid system, Sangre AgroTech’s research team plans to develop scientifically-valid and evidence-based cannabis strains for the production of disease-specific medicines. The goal of this research is to identify, collect, patent, as well as archive a collection of highly-active medicinal strains.

Last month, WEED announced that it acquired the rights to two trademark registrations directed to the name of the company, WEED. The purchases are part of a wider effort by the Company to expand its Intellectual Property (IP) Brands Division into an array of goods and services outside those offered as part of its core goods and services, specifically, the development of cannabis–derived healthcare & adult use Cannabis products. Among other measures, WEED has sought to expand WEED™ and other associated brands including WEED RULES!™ to goods and services, which include cosmetics and cleaning preparations, paper goods and printed matter, and natural agricultural products in addition to others via the filing of numerous trademark applications in the United States Patent and Trademark Office (USPTO).

WEED, Inc. (BUDZ), closed Monday's trading session at $1.74, up 4.19%, on 156,986 volume with 287 trades. The average volume for the last 3 months is 136,367 and the stock's 52-week low/high is $1.03/$15.19.

chart

Blue Eagle Lithium, Inc. (BEAG)

Penny Stock Hub, Jet Life Penny Stocks, Stockwatch, The Street, Wallstreet Online, Investors Hangout, Barchart, Financial Buzz, Simply Wall St, TradingView, Morningstar, MarketWatch, last10k, Street Insider, Market Screener, and Real Investment Advice reported previously on Blue Eagle Lithium, Inc. (BEAG), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Blue Eagle Lithium, Inc. is a lithium exploration and development company based in Henderson, Nevada. It engages in identifying, evaluating, and developing early-stage lithium exploration opportunities in North America. The Company previously went by the name Wishbone Pet Products, Inc. It changed its name to Blue Eagle Lithium, Inc. in July of 2018. Blue Eagle Lithium lists on the OTC Markets Group’s OTCQB.

The Company has a 100 percent Working Interest (WI) in 200 placer claims in Railroad Valley, Nevada, a highly prospective green-fields lithium brine target in the heart of the Basin and Range geologic province. The staked claims encompass 4,000 acres (roughly 1,619 hectares) over a large portion of Railroad Valley. They are ready for the next phase of lithium exploration.

The Railroad Property is about 48 miles to the southwest of Ely, Nevada. Railroad Valley, Nevada is a highly prospective green-fields Petro-Lithium brine target region. It features many similarities to the nearby Clayton Valley.

The primary exploration target within the Railroad Property would be more recent playa sediments, mostly within 2,000 feet (610 meters) of the valley’s surface. Test wells will be drilled to provide lithologic data and lithium analysis samples.

The Railroad Property warrants surface and shallow drilling evaluation for possible surface-mineable lithium-rich units based on diverse sources of geological data. Blue Eagle Lithium’s team will analyze available samples, well logs, as well as seismic data to complete the geologic picture for the Railroad Property in light of present lithium brine-formation theories.

Blue Eagle Lithium announced this past October that it received a completed National Instrument NI 43-101 report from Tekhne Research. The report, commissioned by Blue Eagle in August of 2018, represents an important research tool for the Company to plan an appropriate exploration program for its Railroad Valley property. Tekhne Research (Victoria, British Columbia) was chosen for its experience in Railroad Valley and having conducted NI 43-101 reports for other Lithium exploration companies.

Last month, Blue Eagle Lithium announced it undertook more comprehensive surface soil and water sampling programs to complement the initial encouraging baseline survey acquired in Q3 2018. Blue Eagle, during its most recent site visit in December 2018, collected a further 54 soil samples, 10 rock samples and 8 water samples from hot springs situated within the property. All samples were packaged and shipped for analysis.

Blue Eagle has now completely started its recommended work program following the receipt of the positive NI 43-101 report from Tekhne Research, issued October 2018. Phase 1 is the collection of relevant available data in Railroad Valley and Clayton Valley to build a proprietary database with associated exclusive GIS/3D maps and subsequent interpretation.

Blue Eagle Lithium, Inc. (BEAG), closed Monday's trading session at $0.90, up 5.88%, on 9,849 volume with 10 trades. The average volume for the last 3 months is 34,423 and the stock's 52-week low/high is $0.0625/$3.50.

chart

Oroplata Resources, Inc. (ORRP)

Hotstocked, OTC Markets, InvestorsHub, Emerging Growth, Market Screener, Capital Network, Equities, Penny Stock Tweets, Stockhouse, Stock News Union, Investcom, Marketwired, Stockopedia, Capital Cube, SmallCap Network, and Stock of the Week reported previously on Oroplata Resources, Inc. (ORRP), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Oroplata Resources, Inc., by way of its subsidiaries, engages in the exploration and development of lithium and other minerals. LithiumOre Corp. is a wholly-owned subsidiary of Oroplata Resources. Oroplata engages in the development of lithium brine deposits in the State of Nevada. Oroplata Resources is based in Incline Village, Nevada. The Company’s shares trade on the OTC Markets Group’s OTCQB.

The LithiumOre subsidiary is a lithium resource exploration and development company. LithiumOre’s chief focus is the establishment of a low-cost production base to supply the fast-developing lithium-ion battery industry for mobile devices and laptops, and the accelerating EV (electronic vehicle) industry. LithiumOre holds 1,300 accepted lithium mineral claims, totaling 26,000 acres, located in Railroad Valley of Nye County, Nevada.

LithiumOre has a strategic partnership with 3PL Operating, Inc. for the exploration of the Company's Western Nevada Basin lithium brine project in Railroad Valley, Nevada. 3PL has substantial experience in drilling, development and production of oil and gas that is similar to lithium development since the metal is contained in liquid brines and produced from shallow wells. 3PL will drill on the Railroad Valley to obtain brine samples and evaluate lithium concentrations at the Western Nevada Basin project.

LithiumOre has created a Battery Metals Extraction Division. Its new Battery Metals Extraction Division will be on the Company's current land holdings and close to its Railroad Valley Lithium Project in Nevada. This Division will extract battery metals from its 26,000 acres land holdings in Nevada. Additionally, it will market its extraction technology as a service to other neighboring mining companies and markets for purchase across the nation.

Last month, LithiumOre provided an update on its Battery Metals Extraction Division. Recently appointed to LithiumOre's Advisory Board, Dr. Krishna Sharma has made steady progress within the new Battery Metals Extraction Division. Dr. Sharma is centered on locating the most advanced and cost-effective lithium extraction technology globally.

Dr. Sharma co-founded Sea2K, which is a research and development (R&D) company that develops metal extraction and purification technologies from industrial waste water and effluents. Sea2K developed an extraction technology to recover potassium carbonate from seawater and distillery plants.

Oroplata Resources, Inc. (ORRP), closed Monday's trading session at $0.359, up 8.82%, on 563,956 volume with 160 trades. The average volume for the last 3 months is 462,832 and the stock's 52-week low/high is $0.0575/$0.419.

chart

Dream Homes & Development Corporation (DREM)

Stockhouse, InvestorsHub, Morningstar, TradingView, Digital Journal, YCharts, Wallet Investor, Wall Street Analyzer, Stockwolf, Wallstreet-Online, Penny Stock Hub, Stockwatch, Dividend Investor, Barchart, Simply Wall St. and Investors Hangout reported earlier on Dream Homes & Development Corporation (DREM), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Dream Homes & Development Corporation is a fully integrated real estate company listed on the OTC Markets’ OTCQB. Licensed new home builders and general contractors, Dream Homes is building, raising, renovating and reconstructing homes up and down the New Jersey shore area. Established in 2009, and a full-service construction company, Dream Homes & Development is based in Forked River, New Jersey.  

Dream Homes & Development is equipped to complete all facets of a building project. This includes design, architectural, engineering, and construction. The Company is a full-service building and development enterprise that operates chiefly in the coastal areas of New Jersey.

Dream Homes & Development provides an array of services and products. These include land development and approvals, infrastructure installation, new single and multi-family construction, engineering & structural design, soil studies, architectural and design/build capabilities, and construction management services.

Services and products provided additionally include general contracting of all residential single and multi-family construction, helical and timber pile installation, masonry foundations and concrete work of all varieties, management of home elevation and moving projects and complete finish requirements for all interior construction.

Dream Homes has successfully completed over 1,500 new homes and more than 200 elevation projects. The Company is contracted to develop and construct a 60-unit town home development in Lacey Township, New Jersey over the next two years valued at $12 to $14 million.

At present, Dream Homes & Development has a number of new home properties under contract and in development. These new developments include 13 single family homes, 58 townhomes and 68 waterfront townhomes, all in the Ocean County region of New Jersey.

Dream Homes & Development has its new Modular Division in Point Pleasant, New Jersey. The office and showroom in Point Pleasant allows Dream Homes to better serve the northern Ocean/southern Monmouth region of New Jersey. It complements the main office in Forked River. The showroom offers a complete kitchen, bath, flooring, as well as finish design center. The new Design Center in Point Pleasant has led to growth in modular traffic and sales. In addition, it has facilitated and increased client selections throughout the Company’s entire region.

Dream Homes & Development has completed the acquisition of Premier Modular Homes. Premier has a 23-year record of accomplishment serving southern Ocean County with a focus on Long Beach Island. On October 20, 2018, Dream Homes acquired a substantial portion of the assets of Premier Modular Homes, located in Little Egg Harbor, New Jersey. The acquired assets include physical and intellectual property (IP), such as phone numbers, web site, use of the Premier Modular Home name, equipment, vehicles and trailers. Furthermore, the Company leased the physical premises. This includes the office, showroom, garage, as well as yard space.

Dream Homes & Development Corporation (DREM), closed Monday's trading session at $0.24, even for the day. The average volume for the last 3 months is 235 and the stock's 52-week low/high is $0.11/$0.95.

chart

Bravo Multinational, Inc. (BRVO)

RedChip, InvestorsHub, and MarketWatch reported on Bravo Multinational, Inc. (BRVO), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Bravo Multinational, Inc. is a diversified Company listed on the OTC Markets. Its primary focus is the development and expansion of the Casino Gaming Equipment holdings and business-related activities in Central and South America (specifically Nicaragua, El Salvador, and San Andres, Columbia). The Company previously went by the name Goldland Holdings Co. It changed its corporate name to Bravo Multinational, Inc. in April 2016. Bravo Multinational has its headquarters in Niagara-on-the-Lake, Ontario.

The Company also holds gold/silver mining properties and claims in North America. Its multi-divisional growth strategy is propelled via mergers, acquisitions, and new ventures. At present, Bravo has divisions in Mining Properties and Casino Equipment. Bravo, as it develops, will be adding divisions in International Business Consulting, Wholesale and Manufacturing, and Real Estate Acquisitions.

Concerning Casino Gaming, the Company completed an acquisition transaction on May 6, 2016 with Centro de Entretenimiento y Diversion Mombacho S.A., headquartered in Managua, Nicaragua. On June 1, 2016, Bravo received its first income from this business venture. Additional income payments will be received on the first of each month.

Regarding this transaction, Bravo Multinational will purchase in total 500 slot and video poker gaming machines. All machines have been fully Nationalized and are to be operated under a long-term (year 2033) nationwide national license. Bravo Multinational engaged GameTouch, LLC to coordinate the retail sales segment of Bravo's gaming machines in Nicaragua.

Pertaining to Mining Assets, this involves War Eagle Mines, Silver City, Idaho. Bravo executed a lease agreement with Silver Falcon Mining. This agreement provides for an annual lease payment of $1,000,000 payable in monthly installments of $83,333 per month, and a royalty equal to 15 percent of the proceeds of any ore mined from Bravo property on War Eagle Mountain.

Bravo Multinational is working to expand its business based on five important initiatives. These are the acquisition of existing royalties; providing capital for the exploration, development, and construction of precious metals; monetizing precious metals by-product on existing and future holdings; providing acquisition finance, in partnership with established operating companies, in return for a royalty on the acquired properties; and acquiring mineral properties and leasing the properties to a mining operator receiving rent and royalty payments.

Earlier this month, Bravo Multinational announced that it filed its Q2 ending June 30, 2017, FORM 10-Q with the US SEC. For the three months ended June 30, 2017, Bravo recorded $578,500 in Revenue, and for the six months ending June 30, 2017, the Company recorded $1,251,500 in Revenue. Revenues remain strong over three consistent quarters, as Bravo Multinational’s management works toward profitable quarters, coupled with an increased asset base and decreased liabilities.

Yesterday, Bravo Multinational announced that it completed an asset purchase on August 16, 2017 for 300 slot and video poker machines. This provides an immediate new revenue stream for the Company. The contract is valued at $3,618,000. Bravo anticipates a roughly 30 percent annual return on the assets in Latin America, based on historical income data in similar locations.

Bravo Multinational, Inc. (BRVO), closed Monday's trading session at $0.65, up 8.33%, on 50,585 volume with 24 trades. The average volume for the last 3 months is 15,398 and the stock's 52-week low/high is $0.0209/$0.949.

chart

Impala Platinum Holdings Limited (IMPUY)

Equity Clock, Financial Content, TradingView, MarketWatch, GuruFocus, Zacks, YCharts, OTC Markets, Market Screener, 24hgold, 4-Traders, Capital Cube, Marketbeat, Investopedia, The Coin Guild, The Street, and Emerging Growth reported earlier on Impala Platinum Holdings Limited (IMPUY), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Impala Platinum Holdings Limited is a top producer of platinum and associated platinum group metals (PGMs). The Company is structured around five mining operations and Implats Refining Services, which is a toll refining business. Its operations are located on the Bushveld Complex in South Africa and the Great Dyke in Zimbabwe.

The Company is Implats Platinum Limited’s 96 percent-owned primary operational unit. Impala Platinum Holdings is based in Johannesburg, South Africa. The Company lists on the OTC Markets’ OTCQX.

The Company operates by way of Mining Operations, Refining Services, Chrome Processing, and Other segments. Impala Platinum Holdings produces platinum, palladium, rhodium, and nickel. Impala Platinum has operations on the western limb of the world-renowned Bushveld Complex close to Rustenburg, South Africa. This operation consists of a 13-shaft mining complex and concentrating and smelting plants. The base and precious metal refineries are in Springs, east of Johannesburg.

Implats previously informed of developments pertaining to the Government of Zimbabwe’s intention to compulsorily acquire land measuring 27,948 hectares within its subsidiary Zimplats’ special mining lease area. Implats advised that Zimplats has agreed to release to the Government land measuring 23,903 hectares within Zimplats’ mining lease area in support of the Government’s efforts to enable participation by other investors in the platinum mining industry in Zimbabwe. Subsequent to this release of ground, Zimplats currently holds two separate and non-contiguous pieces of land measuring in total 24,632 hectares.

Implats announced in August of 2018 that its Board of Directors approved the next phase of the implementation of Impala Rustenburg’s strategic transformation. This follows the previous completion of a strategic review aimed at restoring the Impala Rustenburg operation to long‐term sustainability and profitability.

Taking account of the present operating environment and macro-economic realities, the review found that a fundamental business restructuring was the only feasible option to secure a long‐term future for the operation.  

In a phased approach, operations will hence cease at Impala Rustenburg’s end‐of‐life and uneconomic shafts. Future mining activity will center on profitable, lower‐cost, high‐value, and longer‐life assets. The strategic transformation will be implemented over a two‐year period.

Impala Platinum Holdings Limited (IMPUY), closed Monday's trading session at $2.66, up 0.45%, on 20,806 volume with 30 trades. The average volume for the last 3 months is 68,547 and the stock's 52-week low/high is $1.10/$3.09.

chart

RedHawk Holdings Corp. (IDNG)

TopPennyStockMovers, Real Pennies, Greenbackers, Fast Money Alerts, Mad Money Picks, The Observer, Innovative Marketing, Penny Stock General, Stock Shock and Awe, PennyStocks24, and Hot Stock Profits reported earlier on RedHawk Holdings Corp. (IDNG), and we also report on the Company, here at the QualityStocks Daily Newsletter.

RedHawk Holdings Corp. is a diversified holding company listed on the OTC Markets. The Company, via its subsidiaries, engages in the sales and distribution of medical devices, sales of branded generic pharmaceutical drugs, commercial real estate investment and leasing, sales of point of entry full-body security systems, and specialized financial services. RedHawk Holdings was formerly Independence Energy Corp. RedHawk’s subsidiaries are RedHawk Medical, EcoGen Europe, RedHawk Energy Corp., and RedHawk Land & Hospitality. RedHawk Holdings is based in Louisiana.

RedHawk Energy holds the exclusive U.S. manufacturing and distribution rights for the Centri Controlled Entry System. This System is a unique, closed cabinet, nominal dose transmission full body x-ray scanner.

Through its RedHawk Medical Products business unit, RedHawk Holdings sells WoundClot Surgical - Advanced Bleeding Control; the Sharps and Needle Destruction Device (SANDD™); the Carotid Artery Digital Non-Contact Thermometer, and Zonis®.  

RedHawk Medical Products UK Limited is a specialist medical device company. It delivers innovative product solutions to healthcare markets in the United Kingdom (UK), Europe and the Middle East.

EcoGen Europe’s dedication is to healthcare and the NHS. Its commitment is to securing savings across the drug budget in primary care. This is while providing innovation to drive patient care in the acute setting. Last month, RedHawk Holdings announced that it recently completed its financial and legal due diligence and upon execution of final agreements, it will increase its ownership interest in EcoGen Europe to 75 percent.

RedHawk’s financial services revenue is from brokerage services earned in association with debt placement services and investments in oil and gas exploration and production. The Company’s real estate leasing revenues come from varied commercial properties under long-term lease. Moreover, its real estate investment unit holds limited liability company interest in different commercial restoration projects in Hawaii.

EcoGen Europe has signed an exclusive agreement to license and supply a new non-patent infringing generic spray formulation of Sildenafil Citrate in the UK. EcoGen will market the new spray under the brand name Azulvig. EcoGen expects to start marketing Azulvig after receipt of final UK regulatory approval.

RedHawk Holdings has acquired a stake in Tigress Energy Partners. RedHawk agreed to acquire up to a 25 percent interest in Marlin USA Energy Partners, LLC, the minority owner of Tigress Energy Partners, LLC (TEP). The majority ownership of TEP is held by Tigress Holdings, LLC, a limited liability company majority-owned by Cynthia DiBartolo, Chief Executive Officer of Tigress Financial Partners LLC (TFP).

RedHawk Holdings has also completed the re-engineering of its Sharps and Needle Destruction Device (SANDD). It received pre-market clearance from the U.S. Food and Drug Administration (FDA) for the sale of SANDD in the U.S.  RedHawk Medical Products acquired the tangible and intangible property rights to SANDD (formerly known as the Disintegrator™ Insulin Needle Destruction Unit) in December 2015.

In early August, RedHawk Holdings announced that its wholly-owned real estate subsidiary, RedHawk Land & Hospitality LLC, entered into new agreements for the lease of its two commercial properties in Lafayette, Louisiana. The Company said it entered into a new triple-net lease agreement with the Louisiana 3rd Circuit Court of Appeal to renew and extend the present lease term to December 31, 2022. The new lease agreement was effective August 1, 2017 and included certain rate increases.

RedHawk Holdings Corp. (IDNG), closed Monday's trading session at $0.00114, up 3.64%, on 38,000 volume with 3 trades. The average volume for the last 3 months is 1,600,716 and the stock's 52-week low/high is $0.0008/$0.0088.

chart

Esports Entertainment Group, Inc. (GMBL)

Stockrow, Real Pennies, Dividend Investor, Proactive Investors, Capital Network, Infront Analytics, YCharts, OTC Markets, RedChip, Marketbeat, TradingView, Capital Cube, and Wallet Investor reported earlier on Esports Entertainment Group, Inc. (GMBL), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Esports Entertainment Group, Inc. is a next generation, licensed, online gambling business especially focused on esports wagering. Its plan is to offer wagering on esports events in a fully licensed, regulated, and secured platform to the global esports audience, excluding the United States. Esports Entertainment Group has offices in St. Mary's, Antigua, and Barbuda.

Last week, Esports Entertainment Group announced the hiring of two key executives and the opening of its new international headquarters in Malta. Malta was selected because of its strategic location within the European Union (EU), and also access to a highly educated and multi-lingual workforce, particularly in the fields of online gambling.

The Company’s plan is to offer users around the world the ability to participate in multi-player video games tournaments online for cash prizes. At present, the Company is developing several play money websites and its real money wagering website.

Esports Entertainment is a licensed online gambling business with a particular emphasis on esports wagering and 18+ gaming. The Company’s online esports gambling platform will be completely licensed and the highest regulated esports gambling site worldwide.

The Company has been issued a Client Provider Authorization Permit by the Kahnawake Gaming Commission. Esports has applied for an Interactive Wagering License with the Financial Services Regulatory Commission of Antigua and Barbuda to conduct real money interactive gaming on a worldwide basis from centers in Canada and Antigua.

Esports Entertainment has an agreement with PartnerMatrix. This is the first platform that enables online sportsbook and casino operators to run Affiliate System with Agent functionality and Agent System with Affiliate functionality. With the agreement, Esports Entertainment Group will integrate the PartnerMatrix platform to manage its affiliate program on an expedited basis. Esports Entertainment Group has also launched vie.gg. This is the world’s first and most transparent esports betting exchange.

Last month, Esports Entertainment Group announced Affiliate Marketing Agreements with 14 more esports teams as it continues to ramp up affiliate marketing activities in support of its launch of vie.gg. The addition of these 14 esports teams brings the total number of esports team affiliates to 190 since the Company’s first announcement on April 5, 2018.

Esports Entertainment Group, Inc. (GMBL), closed Monday's trading session at $0.64, up 4.07%, on 757 volume with 3 trades. The average volume for the last 3 months is 10,232 and the stock's 52-week low/high is $0.147/$1.35.

chart

AmpliTech Group, Inc. (AMPG)

Wallstreetbuzz, SmallCapVoice, fusionspicks, Jet-Life Penny Stocks, Fortune Penny Stocks, OTCMagic, Ascending Stocks, Information Solutions Group, Pumps and Dumps, HoleinOneStocks, HotStockProfits, Trading Wall St, Penny Stock Gainers, RockingPennyStocks, BestStocksDaily, AllPennyStocks, and PennyStocks24 reported on AmpliTech Group, Inc. (AMPG), and we also report on the Company, here at the QualityStocks Daily Newsletter.

AmpliTech Group, Inc. designs, develops, and manufactures custom and standard state-of-the-art RF Low Noise Amplifiers (LNA) and Power Amplifiers (PA). These are for the domestic and global, SATCOM, Space, and Military markets. In addition, the Company provides consulting services to help with any microwave components or systems design problems. OTCQB-listed, AmpliTech Group has its corporate headquarters in Bohemia, New York.

The Company’s designs cover the frequency spectrum from 50 kHz to 40 GHz - eventually providing designs up to 100 GHz. AmpliTech can provide complex, custom solutions for almost any custom requirements presented to it. It can provide contract assembly of customers' own designs. It uses the most contemporary CAD microwave simulation technology to design and develop from concept to final manufacture of a deliverable product with first-rate accuracy. AmpliTech expects to release new products targeted at the wireless and satellite markets, which will provide advanced technology and performance.

AmpliTech provides its customers with consulting services for their system development. The Company also provides technical assistance in integration and packaging technologies and microwave sub-systems and amplifier related sub-assemblies.

AmpliTech Group has a Joint Venture (JV) Agreement with Trusted Networks, Inc. (TN). The focus of the JV is to develop an affordable mixed signal chipset that can be used at the server/router level and in mobile PDA applications to provide secure and encrypted communication with the objective of preventing hacking and cyber-attacks. TN is a New York, New York based private company with facilities in Colorado Springs and Nashua, New Hampshire.

This past November, AmpliTech Group announced the release of its 3rd Quarter 10Q for 2018. Chief Executive Officer, Fawad Maqbool, stated, “…The Company significantly invested in new product development and as a result, we have purchased new test and assembly equipment to support more growth and productivity. In addition, AmpliTech has upgraded its entire IT system, both hardware and software to current technology, which will also lead to increased productivity and revenues. Our backlog has grown substantially with new contracts resulting from new products and marketing efforts. …We are confident that the financial results of the strategic investment into new technology and marketing will be evident in the next quarter and into the first quarter of 2019."

AmpliTech Group, Inc. (AMPG), closed Monday's trading session at $0.0302, down 24.50%, on 10,000 volume with 1 trade. The average volume for the last 3 months is 57,282 and the stock's 52-week low/high is $0.027/$0.3959.

chart

United Cannabis Corp. (CNAB)

Stockgoodies, Wall Street Wolves, Promotion Stock Secrets, Wealth Insider Alert, Wall Street Mover, Cannabis Financial Network News, StocksImpossible, PricelessPennyStocks, Market Intelligence, Marketbeat, StreetAuthority Daily, Actual Gains, Broad Street, TopPennyStockMovers, PennyStockRumors, Money Map Press, and MyBestStockAlerts reported earlier on United Cannabis Corp. (CNAB), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

United Cannabis Corp.’s commitment is to the development of phyto-therapeutic based products supported by patented technologies for the pharmaceutical, medical, and industrial markets. The OTCQB-listed Company established to provide leadership in the medical cannabis industry. This is through providing patient driven solutions intent on improving biomedical and pharmaceutical pursuits using cannabis-based research, products, and services. A biotechnology company, United Cannabis has its corporate office in Denver, Colorado.

United Cannabis provides consulting services, proprietary products, and licenses its intellectual property (IP) to businesses in the cannabis industry. The Company owns distinct IP relating to the legalized growth, production, manufacture, marketing, management, use and distribution of medical and recreational marijuana and marijuana infused products.

United Cannabis is the creator of Prana Bio Nutrient Medicinals. Its A.C.T. Now Program and Prana Bio Nutrient Medicinals provide a comprehensive solution designed to allow physicians and patients to implement and monitor effective therapy protocols.

The A.C.T. Now program provides nutritional recommendations to help patients suffering from chronic pain, opiate dependency, inflammation, glaucoma, PTSD, neuropathy, multiple sclerosis, fibromyalgia, Crohn’s, IBS, seizures, epilepsy, paralysis, autoimmune, autism, tumors, HIV/AIDS, and many types of cancer.

Prana Bio Nutrient Medicinals is a complete, full spectrum cannabinoid system. It uses the whole cannabis plant through controlling specific cannabinoid ratios, accurate dosing, and manifold non-abrasive delivery methods. United Cannabis has established affiliate relationships with Harborside Health Center of California, Prana Bio Nutrient Medicinals, Bubbleman, Blue River, and Cannabinoid Research & Development (CRD).

United Cannabis has a majority share of Prana Therapeutics, Inc. (PTI). PTI is a clinical stage biotechnology company developing Polymolecular Botanical therapeutics for the oncology, neurology, as well as orthopaedic markets.

Last month, United Cannabis provided an update on its operations. In Q4 of 2018, the academic laboratory of Dr. Brent Reynolds, Cofounder of Prana Therapeutics, Inc., the Company's 95 percent owned subsidiary, was issued a Schedule 1 drug license from the DEA. This License will permit the laboratory to purchase and study the ability of cannabinoids to treat diseases and dysfunctions in laboratory animals.

Furthermore, during Q4, the first delivery of its patented Prana Hemp products was onsite in Jamaica. Distribution throughout the Caribbean started in December.

Mr. Earnest Blackmon, Chief Executive Officer of United Cannabis, said, "While I am certainly disappointed that we had to postpone the expansion of our hemp operation, 2018 was still a substantial growth year for United Cannabis; revenues are up 2,000 percent over 2017. Looking to 2019, I expect we will see continued growth in our existing business, as well as significant contributions from our hemp facility and Jamaica operation."

United Cannabis experienced a 60-day delay in the delivery of industrial hemp processing equipment to its facility in Mead, Colorado. This caused a delay in the scheduled expansion of its capacity at that facility and also related revenue.

United Cannabis Corp. (CNAB), closed Monday's trading session at $0.4325, up 6.53%, on 601,133 volume with 243 trades. The average volume for the last 3 months is 303,075 and the stock's 52-week low/high is $0.30/$1.89.

chart

Zenosense, Inc. (ZENO)

Tip.us, OTC Markets Group, StreetAuthority Financial, Investors Alley, Greenbackers, SmallCapNetwork, MicroCap Gems, Investor Spec Sheet, Wall Street Daily, PennyStocks24, Insider Wealth Alert, The Trading Report, TopStockAnalysts, ProfitableTrading, Pumps and Dumps, DSR News, Wyatt Investment Research, YOLOTraderAlerts, MyBestStockAlerts, PremiereStockAlerts, Dividend Opportunities, and Trade of the Week reported previously on Zenosense, Inc. (ZENO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Zenosense, Inc. is a healthcare technology company headquartered in Valencia, Spain. Its MIDS Medical Ltd. is based in Daresbury, United Kingdom (UK). Zenosense participates in the development of transformational medical diagnostic technologies. These are hand-held devices used at the Point of Care (POC) replacing slow and costly laboratory testing. The Company’s main emphasis, via its joint venture (JV) in MIDS Medical, is the development and commercialization of MIDS Cardiac™. Zenosense lists on the OTC Markets’ OTCQB.

The Company primarily focuses on the development and commercialization of MIDS Cardiac™. This is a POC handheld device for the early detection of certain cardiac event biomarkers to considerably speed up the triage, diagnosis, treatment, and disposition of patients reporting chest pain and with suspected acute myocardial infarction (heart attack). MIDS Cardiac™ is undergoing development for use at the POC for the fast testing of cardiac markers delivering results equal or superior to laboratory gold standard accuracy within minutes.

The MIDS patented technology utilizes a tailored optical sensor like other devices. In addition, it utilzes miniaturized, highly sensitive custom built “Hall Effect” magnetic sensors embedded within a test strip as a Lab-On-Chip device. MIDS has strong patent protection. The MIDS technology platform (under license) is protected by patent applications. The intention of MIDS Cardiac™ is to perform high sensitivity troponin assays at the POC, utilizing a Magnetic Immunoassay Detection System (MIDS technology), an intellectual property (IP) used under license and undergoing further development by MIDS Medical.

Recently, Zenosense announced that its MIDS Medical Ltd. JV (MML) entered a staged funding for the next phase of development of MIDS Cardiac. On August 31, 2018, MML entered into an agreement with a third party investor for financing of up to a total amount of $1,200,000. The expectation is that this funding will cover the costs of the next important development phase of the MIDS Cardiac microfluidic test strip that aims to embody a high sensitivity (HS) troponin assay or an alike assay to prove the MIDS system on a live test.

With this Agreement, MML will receive an initial total amount of $300,000 in exchange for ordinary shares in MML, representing a 2.91 percent equity ownership, with the option to make scheduled payments up to an additional $900,000. The full $1,200,000 investment would equate to a final 10.31 percent equity ownership in MML.

At the beginning of October, Zenosense announced that its MIDS Medical Ltd. JV, MML, expanded its technical team to support the next phase of development of MIDS Cardiac. Following its recent funding agreement, MML arranged the services of three important contractors for its next phase of MIDS development. The design of these contracting arrangements is to efficiently obtain services as and when required by MML.

Zenosense, Inc. (ZENO), closed Monday's trading session at $0.2055, up 8.16%, on 8,943 volume with 14 trades. The average volume for the last 3 months is 44,647 and the stock's 52-week low/high is $0.15/$0.89.

chart

The QualityStocks Company Corner

Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE)

The QualityStocks Daily Newsletter would like to spotlight Pacific Rim Cobalt Corp. (OTCQB: PCRCF).

NetworkNewsWire released a report on the company detailing how Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) is “One to Watch.” Read more »

Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) is a Canada-based exploration company focused on the acquisition and development of production-grade cobalt deposits, a key raw material input for the growing lithium-ion battery industry.

Pacific Rim Cobalt and its Cyclops Nickel-Cobalt Project, located in the Depapre District, Jayapura Regency, Papua Province, Republic of Indonesia, is uniquely positioned in a region with potentially the largest source of cobalt outside of Africa. Strategically located near China, the world’s largest cobalt buyer, the Cyclops Project is a laterite (iron-hosted) mineral prospect, rich in cobalt and nickel. Cobalt consumption in China is on-track to use over 8,000 tonnes of cobalt annually by 2021 for electric vehicle production alone and is projected to remain the world’s largest cobalt consumer for many years to come.

Global demand for renewable power is fueling a massive shift from traditional energy supply chain economics to cobalt-reliant lithium-ion batteries, the world’s most widely used power source for portable applications such as electric vehicles and other high-tech applications.

Pacific Rim Cobalt management has concluded that strategic access to major markets offers the most important factor to servicing the rising demand for cobalt. The company’s acquisition of its initial asset in Indonesia offers near surface, strong nickel-cobalt mineralization in an area with excellent infrastructure including a nearby workforce, supplies, sealed roads, ocean access, nearby port facility and gentle topography. The project area, nestled on the north coast of Papua, Indonesia, establishes Pacific Rim Cobalt well within the economically attractive ocean-going transportation range to Asia and its lucrative, growing industrial markets.

Exploration efforts are currently focused on establishing a maiden compliant resource for the Cyclops project, both in historically identified and drill-tested prospects as well as previously unexplored areas of the claims. During the first nine months of 2018, the company focused on assembling the necessary agreements to access northern areas of the project hosting historically identified mineralized zones. Mapping, sampling and a mini-bulk sample within the mineralized zones has been completed, along with a small-scale program in the previously unexplored far southern area of the project. With surface access to priority targets now established, Pacific Rim Cobalt will initiate drilling and extract additional mini-bulk samples for further metallurgical testing.

“We are excited and optimistic about the unique possibility of developing this project into an asset that will add shareholder value and position the company to play a future role in the battery metals supply chain,” Pacific Rim Cobalt CEO Ranjeet Sundher recently stated (http://nnw.fm/u1HNs). “We expect the near-surface nature of cobalt/nickel mineralization at the Cyclops project will lend itself well to low-cost, logistically straightforward drilling. We thus anticipate the opportunity to undertake a resource calculation study, as well as ongoing metallurgy and process option testing, will present itself in the near future. It’s going to be a busy year ahead, and we look forward to getting the drills turning and building value.”

Pacific Rim Cobalt’s world-class management team includes Sundher, who has over 20 years of capital markets experience. Sundher is also president of Canrim Ventures Ltd., a Singaporean advisory firm specializing in early stage project finance and structure. He previously founded Indogold Exploration, a Jakarta-based mining service firm, and has raised over $40 million for companies in which he was a founder/partner.

Chief Financial Officer Steve Vanry has 25 years of professional experience in senior management positions with public and private natural resources companies, providing expertise in capital markets corporate finance, mergers and acquisitions, regulatory compliance, accounting and financial reporting.

Andre Talaska serves as country manager and technical supervisor. He has over 30 years of experience in the mining and exploration industry and has held senior positions with several companies in Australia and southeast Asia. Shakir Juffry, business development/engineering, is a chemical engineer and extractive metallurgist by background training who has over 20 years of experience in the Indonesian mining and minerals exploration field. Toto Suarto Sajali, operation and development manager, is a mining engineer with over 15 years of experience in Indonesian project assessment, development and operations.

Pacific Rim Cobalt Corp. (OTCQB: PCRCF), closed the day's trading session at $0.09, off by 10.89%, on 9,871 volume with 8 trades. The average volume for the last 3 months is 14,086 and the stock's 52-week low/high is $0.0701/$1.165.

Recent News

chart

Pressure BioSciences Inc. (PBIO)

The QualityStocks Daily Newsletter would like to spotlight Pressure BioSciences Inc. (PBIO).

Pressure BioSciences, Inc. (OTCQB: PBIO), today announced the commercial launch of its Biopharmaceuticals Contract Services Business. The launch of this new business has been eagerly anticipated following the Company's acquisition of the assets of BaroFold, Inc. in December 2017, including patents, equipment, and other intellectual property relating to Barofold's unique, high pressure-based protein disaggregation and refolding platform.

Pressure BioSciences Inc. (PBIO) develops, markets and sells proprietary laboratory instrumentation and associated consumables to the life sciences sample preparation market. Sample preparation refers to the wide range of activities that precede most forms of scientific analysis. It is often complex and time-consuming, yet a critical part of scientific research. The market for sample preparation products is currently estimated at $6 billion worldwide.

The Company’s product line can be used to exquisitely control the sample preparation process. It is based on a patented, enabling technology platform called pressure cycling technology (“PCT”). PCT uses alternating cycles of hydrostatic pressure between ambient (14.5 psi) and ultra-high levels (up to 100,000 psi) to safely and reproducibly control critical biological processes, such as the lysis (breakage) of cells, the digestion of proteins, and the inactivation of pathogens.

Pressure BioSciences’ product line is led by its newly released, next-generation Barocycler 2320EXTREME instrument. Named a finalist in the prestigious 2017 R&D Awards (also known as the “Oscars of Innovation”), the Barocycler 2320EXT is already being touted by some key opinion leaders as an essential element of the $1.8 billion U.S. “Cancer Moonshot” program. For example, Professor Phil Robinson, Co-head of the cancer research center of the Children’s Medical Research Institute (Sydney, Australia), said in a recent interview: “We are collecting the whole proteome on 70,000 tumor samples from all classes where complete clinical outcome is known. Due to its unique capabilities, the Barocycler 2320EXT has become a critical part of our program. It is the primary enabler of the high-throughput component of the project. Without this step, our project simply could not be done. In fact, the Barocycler 2320EXT works so well we have just purchased two more.”

Momentum is building when it comes to the potential for using the Company’s unique PCT technology platform. Leading scientists are intrigued by Pressure BioSciences’ approach, which among other attributes, revolutionizes the process of rupturing cells (lysis) for further study, yielding superior biomolecules for investigation. The Company’s technology transcends current methods of breaking open cells, which use chemicals, blades, metal beads, or other damaging and altering methods that can ultimately adversely affect the result for researchers. Pressure BioSciences’ PCT technology utilizes customized, controlled hydrostatic (water) pressure to rupture cells in a chamber, enabling exquisitely customized levels of pressure to optimally break open different types of cells at prescribed pressure levels—something never before accomplished in a commercial setting. Using this pioneering method, the result is a truer, more legitimate sample, which boosts the efficacy of research and the quality of results. The potential impact of this technology on scientific advancement is enormous, enabling research scientists to begin their studies with biological samples of unprecedented integrity, with the potential to improve research outcomes at the earliest, most critical step. PCT can additionally inactivate pathogens (e.g., viruses, bacteria) using hydrostatic pressure, making the samples safer to study—another innovation with astronomical potential for application in a variety of markets.

The Company’s high-pressure instruments for research purposes are marketed throughout the United States, Europe, China and Japan. To date, Pressure BioSciences has installed nearly 300 PCT Systems in over 165 leading academic, government, biotech and pharma laboratories around the world. Its primary applications are in biomarker discovery, forensics, agriculture and pathology. Over 100 scientific papers have been published on the advantages of the PCT platform, which is also being used in the specialized fields of drug discovery and design, bio-therapeutics characterization, soil and plant biology, vaccine development and histology.

Impressive as their biotech business is, there is more to the PBI story. Pressure BioSciences recently received two patents in China for its novel Ultra Shear Technology (UST), a process that has potential in a wide range of industrial applications, including extending the shelf life of some food products and making two insoluble liquids (like oil in water) soluble. Patents have also been filed in many other countries worldwide. UST is a novel technique based on the use of intense shear forces generated from ultra-high-pressure valve discharge.

This important technology has the potential to play a significant role in a number of commercially important areas through its ability to create high-quality, stable nanoemulsions. Scientific studies indicate that improved absorption, higher bioavailability, greater stability, lower surfactant levels and other advantages can be achieved with nanoemulsions – all hugely important factors in the fields of nutraceuticals, cosmetics, pharmaceuticals, and in various medical products. There is an enormous opportunity in the cannabis market, since the technology can potentially reduce oil droplets containing cannabidiol (CBD) to nanoparticles, after which they can be safely suspended in a stable water solution—something many companies have endeavored to achieve without success. Researchers looking for a way to increase the bioavailability of cannabinoids in the body will find this technology a game changer.

The Company’s UST technology also has possibilities in the production of clean label foods, which are currently processed using several innovative methods, including high-pressure treatments (such as Starbucks’ Evolution line of juices). In 2015, the worldwide market for high-pressure processed (HPP) food was estimated at U.S. $10 billion. UST uses ultra-high pressures and certain valves to generate intense shear forces under controlled temperature conditions to produce nanoemulsions, and which also significantly reduces food-borne pathogens. Pressure BioSciences’ initial focus with this technology will be to evaluate UST for the production of high-quality dairy products and beverages.

Pressure BioSciences Inc. (PBIO), closed the day's trading session at $2.29, up 4.09%, on 729 volume with 2 trades. The average volume for the last 3 months is 4,613 and the stock's 52-week low/high is $1.519/$5.00.

Recent News

chart

Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX)

The QualityStocks Daily Newsletter would like to spotlight Foresight Autonomous Holdings Ltd. (FRSX).

Foresight Autonomous Holdings Ltd. (NASDAQ and TASE: FRSX), announced today that its wholly owned subsidiary Eye-Net Mobile Ltd. has successfully completed initial integration by installing the Eye-Net™ application’s communication layer on the data center of a leading Israeli cellular provider. Eye-Net™ is a V2X cellular-based accident prevention solution, designed to provide pre-collision alerts in real time to pedestrians and vehicles by using smartphones and relying on existing cellular networks.

Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX), founded in 2015 and headquartered in Israel, is a technological innovator in automotive vision systems and driver assistance technology. Through its wholly owned subsidiary, Foresight Automotive Ltd., Foresight is engaged in the design, development and commercialization of stereo/quad-camera vision systems and V2X cellular-based solutions for the automotive industry based on 3D video analysis, advanced algorithms for image processing and sensor fusion. The company’s powerful and patented stereoscopic technology is derived from field-proven technology that has been deployed throughout the world for almost two decades.

Foresight’s innovative autonomous driving solutions are based on mature, proprietary stereoscopic image technology that uses two synchronized cameras to mimic human depth perception and produce a three-dimensional image. This 3D image can anticipate possible collisions with other vehicles, cyclists, pedestrians and other obstacles. The technology provides highly accurate real-time alerts about the vehicle’s surroundings while in motion. The systems are designed to improve driving safety by enabling highly accurate and reliable threat detection while ensuring the lowest rates of false alerts.

The company’s patents provide IP protection for its robust and proven proprietary stereoscopic technology, which was developed using the security technology of Foresight’s major shareholder, Magna B.S.P.

Foresight has developed three main products:

  • QuadSight™. This breakthrough detection system sets the bar for autonomous vehicle vision. It features nearly 100 percent obstacle detection with almost zero false alerts and operates optimally under all weather and lighting conditions, including darkness, rain, fog, haze and glare. QuadSight™ is the first quad-camera multi-spectral vision solution of its kind, driven by advanced and proven image processing algorithms. The system consists of two sets of stereoscopic infra-red and visible-light cameras that enable highly accurate and reliable obstacle detection for seamless 24/7 vision.
  • Eyes-On™. This solution uses advanced algorithms for accurate depth analysis and obstacle detection to provide a unique stereo vision Advanced Driver Assistance System (ADAS). It can detect all potential obstacles regardless of shape, form or material, including other vehicles, cyclists, pedestrians and animals. It has an accuracy and reliability of almost 100 percent and near zero false alerts.
  • Eye-Net™. This is a cellular-based accident prevention solution that is designed to provide real-time pre-collision alerts to vehicles and pedestrians. This proprietary system is deployed on smartphones and cloud-based servers operating on existing cellular networks, and it eliminates the need for additional designated hardware. Eye-Net™ is designed to provide a complementary layer of protection to advanced driver assistance systems and extends this protection to road users who are not in direct line of sight. It is optimally designed for both urban environments and high-speed scenarios to provide protection for the most vulnerable road users. On March 28, 2018, Foresight announced that it had completed a successful feasibility study of its Eye-Net™ accident prevention solution involving 120 users of Android and iOS cell phones located across Israel.

In 2017, Foresight sought more opportunities within the international market. The Company signed pilot agreements with three leading car manufacturers in China and completed pilot projects meeting all pre-defined requirements and criteria. In addition, FRSX completed a pilot project with Uniti Sweden.

Studies by the Insurance Institute for Highway Safety continue to emphasize the dramatic reduction in accidents and injury-related crashes reported when vehicles are equipped with collision avoidance systems. A recent study by the Institute states that the rate of single-vehicle, sideswipe and head-on crashes was 11 percent lower in vehicles with the warning systems. More importantly, the study shows collision avoidance technology cut the rates of injury crashes of the same type by 21 percent.

Foresight Autonomous Holdings, Inc. also holds a 32 percent interest in RailVision, a company that develops advanced systems for railway safety and maintenance. RailVision has successfully completed 13 tests in Israel, Germany, Italy and Switzerland in addition to a real-time system test with a European railway operator. Over the course of 2017, RailVision successfully completed rounds of financing totaling $5.8 million and started the process of licensing the system according to European standards.

Haim Siboni is the founder of Foresight and has served as the company’s chief executive officer and director since 2015. Siboni, a passionate entrepreneur, has an extensive background in the marketing and business management sectors in the fields of electronics, video, TV, multimedia, computerized systems, line and wireless telecommunication, design and development of systems and devices, including electro-optic radar systems. He is the founder and CEO of Magna B.S.P., Foresight’s major shareholder and a leading innovator in the field of homeland security surveillance solutions.

Foresight Autonomous Holdings Ltd. (FRSX), closed the day's trading session at $1.8808, up 2.78%, on 14,098 volume with 43 trades. The average volume for the last 3 months is 22,388 and the stock's 52-week low/high is $1.47/$7.30.

Recent News

chart

CytoDyn Inc. (CYDY)

The QualityStocks Daily Newsletter would like to spotlight CytoDyn Inc. (CYDY).

CytoDyn Inc. (OTC.QB: CYDY), a biotechnology company developing a novel humanized CCR5 monoclonal antibody for multiple therapeutic indications, announces that its board of directors elected Richard G. Pestell, M.D., Ph.D., M.B.A., F.A.C.P., F.R.A.C.P., Chief Medical Officer, and director to the additional position of Vice Chairman of the board of directors.

CytoDyn Inc. (CYDY) is a biotechnology company focused on the clinical development and potential commercialization of a new class of HIV/AIDS therapeutics or viral-entry inhibitors intended to protect healthy cells from viral infection. The company’s pipeline includes its lead product, PRO 140 for multiple indications among which are human immunodeficiency virus (HIV), graft-versus-host disease (GvHD), colon cancer, and multiple sclerosis (MS), each in various stages of development. CytoDyn first approval is focused on HIV indications for two different HIV populations.

PRO 140 is a humanized monoclonal antibody directed at CCR5, a molecular portal that HIV uses to enter T-cells. PRO 140 works by blocking the predominant HIV (R5) subtype entry into T-cells by masking this required co-receptor, CCR5.

CytoDyn has completed one pivotal phase 3 clinical trials of PRO 140 use in combination with current drugs for population that has limited treatment options. PRO 140 is also currently in another phase 3 (investigative trial) for a second approval for another HIV population. HIV continues to be a major global public health issue. There is no cure for the disease that has claimed more than 35 million lives to date, according to the World Health Organization (“WHO”). In 2017, 940,000 people around the world died from HIV-related causes. There were approximately 36.9 million people living with HIV at the end of 2017 with 1.8 million people becoming newly infected during that same year. The WHO estimates there were 21.7 million people globally receiving antiretroviral therapy (“ART”) in 2017.

HIV targets the immune system and weakens the body’s defense systems against infections and some types of cancer. As the virus destroys and impairs the function of immune cells, infected individuals gradually become immunodeficient which results in increased susceptibility to a wide range of infections, cancers and other diseases that people with healthy immune systems can fight off. The most advanced stage of HIV infection is Acquired Immunodeficiency Syndrome (AIDS), which can take from 2 to 15 years to develop depending on the individual.

PRO 140 functions by blocking the HIV co-receptor CCR5, a molecular portal HIV uses to enter T-cells, thus preventing the HIV virus from entering the cell. CCR5 is a protein located on the surface of white blood cells that normally serves as a receptor for chemicals that attract immune cells to the site of inflammation. Clinical trials to date indicate PRO 140 does not interfere with these normal CCR5 functions. Results from phase 1 and phase 2 human clinical trials have shown PRO 140 significantly reduces viral burden in people infected with HIV. Importantly, in a recent phase 2b clinical trial, PRO 140 demonstrated it can allow a subset of R5 strain of HIV population to replace their current HIV regimen (Highly Active Antiretroviral Therapy or “HAART.”) by a simple sub-cutaneous self-injectable dose of PRO 140 which is administered once a week. Some of those patients have received PRO 140 as their only therapy for almost four years.

The PRO 140 antibody appears to be a powerful antiviral agent with hardly any side effects, toxicity. More than 500 patients have used PRO 140 in clinical trial and no resistance has ever been developed in any patients including patients in monotherapy of PRO 140 for almost four years.

PRO 140, which is taken as an easy-to-use, weekly, subcutaneous self-administered dose, has almost no side effects or toxicity with no report of any serious adverse event related to PRO 140 in more than 500 patients in eight different clinical trial.

As we indicated earlier patients given PRO 140 showed no drug resistance on monotherapy for some almost four years while 76% of HAART patients developed a resistance to some portion of the lifetime drug regimen. Patient compliance with HAART is also the main reason why only 35% of HIV patients in US reporting complete viral load (VL) suppression which is VL<50 cp/mL.

In addition to its research into the powerful potential of PRO 140 for use in HIV patients, CytoDyn is pursuing PRO 140 as a therapeutic anti-viral agent in other non-HIV indications that could benefit from PRO 140’s ability to block CCR5. These immunologic indications include new reactions to cancer, transplantation rejection, autoimmune diseases and chronic inflammation such as Multiple Sclerosis. The company sees the significant potential for multiple pipeline opportunities for PRO 140.

The U.S. Food and Drug Administration has designated PRO 140 as a “fast track” product for HIV and granted Orphan Drug Designation to it for the prevention of GvHD in transplant patients. CytoDyn has initiated its first clinical trial with PRO 140 in an immunological indication for GvHD in patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) who are undergoing bone marrow stem cell transplantation. The company is also investigating PRO 140 in animal models of cancer progression and autoimmunity with positive results and has published its animal study results in GvHD in peer-reviewed journal.

CytoDyn president and CEO Nader Z. Pourhassan, Ph.D. joined the company in 2008 and is credited for purchasing PRO 140 from Progenics in 2012 and has taken a new path to approval for the product. He is the co-inventor of monotherapy path for PRO 140. He has taken PRO 140 development from phase 2 to Completed successful phase 3 in about four years. He now has more than 10 years of drug development experience and has overseen the rapid clinical development of PRO 140 as a therapy for HIV into two phase 3 for two different indications. He also initiated PRO 140 first immunological indication in GvHD (currently in phase 2). He is also involved in preclinical and clinical development of PRO 140 in additional immunological indications.?Dr. Pourhassan, who has more than 20 years of business development experience, has led CytoDyn’s capital market activities since joining the company in 2008. He received his Bachelor of Science from Utah State University, Master of Science from Brigham Young University, and his Ph.D. in Mechanical Engineering from the University of Utah and is the author of three books.

CytoDyn Inc. (CYDY), closed the day's trading session at $0.57, up 4.68%, on 311,150 volume with 100 trades. The average volume for the last 3 months is 187,665 and the stock's 52-week low/high is $0.40/$0.836.

Recent News

chart

Sproutly Canada, Inc. (OTCQB: SRUTF) (CSE: SPR) (FRA: 38G)

The QualityStocks Daily Newsletter would like to spotlight Sproutly Canada, Inc. (SRUTF).

As savvy cannabis investors look toward the market potential of the beverage-ization of their natural plant products, suppliers such as Sproutly Canada, Inc. (OTCQB: SRUTF) (CSE: SPR) (FRA: 38G) are strengthening their operations by adding more experienced executives, building their distribution networks and increasing their output capabilities.

Sproutly Canada, Inc. (OTCQB: SRUTF) (TSX.V: SPR) (FRA: 38G) is developing and bringing to market cannabis consumer products with a focus on beverages. The company’s core mission is to become the leading supplier of water-soluble cannabis solutions and bio-natural oils for brands in the emerging cannabis beverage and edibles market.

To make this happen, Sproutly acquired Infusion Biosciences to bring to market a patent-pending Aqueous Phytorecovery Process (APP) technology, a fundamental paradigm shift within the cannabis industry. Replacing traditional water-compatible solutions with true natural water solubility improves the body’s ability to utilize cannabinoids, making the effect of the cannabis almost immediate.

This revolutionary process doesn’t alter the cannabis compounds and provides an onset time and offset time that mimics the same effects as inhaled marijuana. That means consumers may feel effects in five minutes or less and be free from the desired effect in approximately 90 minutes—a vastly different ingestion pattern than current methods. In addition, the water-based cannabinoids can be mixed with other liquids and stay dissolved in those liquids. The application of water-soluble cannabis infusions has potential to be widespread in both medicinal and recreational cannabis sectors, giving Sproutly a distinctive edge in a market with untapped potential.

Sproutly’s business model is focused on processing rather than cultivating, which means its success is not constrained to growing its own cannabis. The company does own a Toronto-based, ACMPR-licensed facility designed and built with a focus on cultivating pharmaceutical-grade cannabis to produce and formulate the first natural, truly water-soluble cannabis solution. Its water-soluble ingredients and bio-natural oils will deliver revolutionary brands to international markets that are searching for well-defined commercial products.

Sproutly’s entrance in the cannabis market is perfectly timed as cannabis is moving towards mainstream acceptance. Potential users are, however, interested in consuming cannabis products as drinks and using it as oils rather than smoking. The potential cannabis beverage market is staggering, and with Sproutly owning the exclusive rights to APP technology in Canada, Australia, Jamaica, Israel and the entire European Union, the company is looking at significant international expansion opportunities.

Sproutly plans to capitalize on these international opportunities by executing on partnerships with local and globally established consumer brands to leverage their existing customer bases, expand brand loyalty, and assist with marketing and support distribution networks to deliver scientific breakthroughs with speed and efficiency?worldwide.

Management

Sproutly believes that talent drives growth. The company is committed to bringing together the best and brightest minds in the cannabis space to help with their mission to disrupt the global beverage and consumables market.

President, CEO and Director Keith Dolo recently served for more than 13 years with Robert Half, an S&P 500, NYSE-listed company. At Robert Half, Dolo held the position of vice president for more than eight years, as well as other senior roles in both operations and sales. He also sits on an advisory committee and a board position for two nonprofits in Vancouver, BC.

Chief Science Officer and Director Dr. Arup Sent has more than 35 years of experience in research and executive management at biotechnology and pharmaceutical companies. He was awarded a PhD in biochemistry from Princeton University and is a former faculty member at the National Cancer Institute and Scripps Research Institute. Sen is the inventor on five U.S. patents and numerous international patents and patent-pending applications.

Chief Financial Officer Craig Loverock is a chartered professional accountant with over 20 years of experience in accounting and finance roles in Canada, the United States and the United Kingdom. He has extensive expertise in public company reporting and transactional experience, having served as the senior financial advisor to the chairman at Magna International and acting as chief compliance officer and CFO for a private equity firm.

Head Grower Frank Han has over 12 years of experience in the horticulture industry. A previous master grower in a large commercial facility, Han has impressive expertise in all growing methods, techniques and procedures. He brings with him a wealth of knowledge in cloning, nutrient and overall plant management. Han will be in charge of the production team at Sproutly’s Toronto Herbal Remedies facility.

Sproutly Canada, Inc. (OTCQB: SRUTF), closed the day's trading session at $0.34, up 2.10%, on 662,359 volume with 205 trades. The average volume for the last 3 months is 205,121 and the stock's 52-week low/high is $0.189/$1.875.

Recent News

chart

QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX-V: QMC) (FSE: 3LQ)

The QualityStocks Daily Newsletter would like to spotlight QMC Quantum Minerals Corp. (QMCQF).

Exploration at QMC Quantum Minerals’ (OTC: QMCQF) (TSX.V: QMC) (FSE: 3LQ) Irgon Lithium Mine Project commenced almost half a century ago, leaving existing infrastructure for the company to utilize. To view the full article, visit: http://nnw.fm/Y8aei.

QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX-V: QMC) (FSE: 3LQ) is a British Columbia based company engaged in the business of acquisition, exploration and development of natural resource properties. QMC’s focus is on creating shareholder value through strategic acquisition and development of high quality lithium, silver, gold, nickel, copper and zinc prospects.

QMC’s current properties are in the Canadian province of Manitoba, one of Canada’s most productive, centrally located mining regions. These resources include the Irgon Lithium Mine project and two Volcanic Massive Sulphide (“VMS”) properties – the Rocky Lake and Rocky-Namew known collectively as the Namew Lake District Project – which contain base metal-rich mineral deposits. Excellent access and well-developed mining infrastructure to the company’s wholly-owned Irgon Lithium Mine Project offers significant value and ramps up the near-term production schedule, putting QMC in a position to take advantage of rising lithium prices.

The region’s historic resource estimate of lithium is well documented in a 1956 Assessment Report developed by a previous owner, Lithium Corporation of Canada Ltd. The project’s historical resource estimate of 1.2 million tons grading 1.51% lithium-oxide over a strike length of 365 meters and to a depth of 213 meters is being updated by QMC through a detailed channel sampling and subsequent drill program.

North Face Software Ltd. recently created an interactive 3-D model of the Irgon Dike utilizing all historical data derived from past drilling and underground work. The 3-D model clearly demonstrates that exploration and underground development has only taken place on the central portion of the dike, leaving significant potential to quickly increase tonnage.

The company’s latest assay results, obtained from 144 channel samples at QMC’s Irgon Lithium Mine Project, provided encouraging and positive results that compare favorably with the historic assays. QMC has received a drill permit from the Sustainable Development Office of the Manitoba government and is in the process of requesting and assessing bids from drilling contractors. The company plans to begin a 2,000-meter drill program to confirm the historic lithium oxide assay results documented in the historic 1953-54 drill program.

QMC’s experienced leadership team includes specialists in mineral exploration, geology, engineering, new business development, marketing and investor relations. The company’s team of qualified advisors includes consultant Bruce E. Goad, P.Geo., who has 40 years of experience in mineral exploration in Canada, Argentina, Asia and Africa. As a Qualified Person, Goad has worked on numerous deposit styles including rare element pegmatites, porphyry, banded iron formation (BIF) gold deposits, skarn, greisens,  and VMS. He has a wide and varied skill set which includes precious, base, industrial and rare metal projects with a sharp focus on gold exploration. Goad is the author of several scholarly publications on pegmatite granites of the southeastern Manitoba region.

The market for lithium has surged over the past three years with prices per metric ton tripling. The world’s rising demand for portable power can easily been seen in the electric vehicle and mobile device industries – both of which use lithium-based, renewable batteries as a power resource. QMC’s high potential prospects and experienced management team, both in geology and corporate finance, put QMC and its shareholders in an excellent position to take advantage of the lithium, precious and base metals markets.

QMC Quantum Minerals Corp. (QMCQF), closed the day's trading session at $0.1728, up 1.65%, on 27,620 volume with 23 trades. The average volume for the last 3 months is 66,131 and the stock's 52-week low/high is $0.1155/$0.9204.

Recent News

chart

Choom Holdings Inc. (CSE: CHOO) (OTC: CHOOF)

The QualityStocks Daily Newsletter would like to spotlight Choom Holdings Inc. (CHOOF).

Choom Holdings Inc. (CSE: CHOO) (OTC: CHOOF) was featured today in a report by CannabisNewsWire explaining how, as the year comes to an end, many investors are evaluating their portfolios and are planning how to reallocate funds from losing investments to other avenues where the earning potential is higher. If you plan to make money from the cannabis industry, read on and discover the three trends that you can consider as you make your 2019 investment allocations.

Choom Holdings Inc. (OTC: CHOOF) (CSE: CHOO) channels the laid-back spirit of Hawaii to the Okanagan region of British Columbia with a generous nod to the inspirational, yet unofficial, history of the 1970s “Choom Gang,” a group of buddies in Honolulu (including former President Barack Obama) who knew how to relax with “choom,” the local’s term for marijuana. Choom’s trademark slogans pivot off another unconventional phrase (“Say Hello to…”), bringing a heady dose of good times and good friends together as the company invites investors to “Say Hello to Choom™” as it lights up the adult recreational cannabis market in Canada.

Choom™ has been an ACMPR (Access to Cannabis for Medical Purposes Regulations) applicant since November 2013 in Vernon, B.C. The company’s first application has received security clearance and is now in the detailed review stage. They also recently announced their second late-stage ACMPR application, which is in its confirmation of readiness stage. Cannabis Compliance Inc. has been retained to help expedite Choom’s initial license applications to ensure the company’s readiness for legalization of recreational marijuana in Canada mid-summer 2018.

True to the company’s character, Choom™ is retrofitting two large facilities – No. 1 in Vernon, B.C., and No. 2 on Vancouver Island – to house its cannabis growing facilities. Phase 1 of the Vernon property will provide Choom™ with 6,800 square feet of growing space, capable of producing 660 kg/year of cannabis at an estimated revenue of $6.6 million, excluding oils. The company expects this facility to be completed by July 2018, the same month that Canada is expected to formally legalize recreational marijuana for adult use. A potential Phase 2, to be completed by the end of 2018, would add another 6,800 square feet for a total of 1,500 kg/year capacity, which would nearly double No. 1’s revenue. A Level 9 vault is also planned with a storage capacity of 15,000 kg. While the No. 2 facility on Vancouver Island is smaller – 4,500 square feet – its retrofit is also slated to be completed by July 2018. Plans include doubling this space as well, which would add about $9 million in annual revenue, excluding cannabis oils.

Choom™ announced its retail dispensary strategy with the intention of establishing market leadership in reaching the Canadian cannabis consumer. The partner program is already in the retail space design stage as the company seeks to build a chain of branded retail cannabis dispensaries in jurisdictions in Canada where recreational cannabis is legal. Choom™ Stores will have a cool, modern layout and design created to emit an authentic “Aloha” vibe. Choom™ is all about producing high-grade cultivars and curating them for a bigger audience.

A savvy, experienced management team includes Chris Bogart, president and CEO; John Oh, R.P.I.C., Operations Manager; Robert Bayrack, Master Grower, S.P.I.C.; and Adrian Robinson, Strategic Advisor. Bogart has over two decades of international experience in capital markets and was a co-founder of InMed Pharmaceuticals and Magnum Uranium. He has structured complex equity financing transactions in the U.S., Europe and Canada. Bogart is joined on the Board of Directors by Kevin Pull, Stephen Tong and John Oh.

While the medical marijuana industry is expected to double by 2021 to 500,000 registered users, the true highlight of the recreational cannabis represents the key cultural shift set to launch in Canada. With an estimated $4.9B to $8.7B retail market coming, now is the right time for a Recreation Brand like Choom™ to be involved in this growing industry. Establishing and maintaining Choom™ premium brand loyalty is a key factor in the company’s growth strategy. Get ready to “Say Hello” to opportunity, good times and good friends with Choom™.

Choom Holdings Inc. (CHOOF), closed the day's trading session at $0.3749, up 3.62%, on 233,840 volume with 142 trades. The average volume for the last 3 months is 385,452 and the stock's 52-week low/high is $0.285/$1.129.

Recent News

chart

Net Element (NASDAQ: NETE)

The QualityStocks Daily Newsletter would like to spotlight Net Element (NETE).

World finance technology innovator Net Element, Inc. (NASDAQ: NETE) is building its own capital potential as well as that of its customers, announcing recently that it has acquired cash flow assets that are expected to generate well over $4 million in gross profits over the next four years and continued profits thereafter.

Net Element (NETE), is a global financial technology and value-added solutions group that supports electronic payments acceptance in an omni-channel environment spanning across point-of-sale, e-commerce, and mobile devices. Net Element operates a payments-as-a-service transactional model and value-added services platform for small to medium enterprises in the U.S. and selected emerging markets. Internationally, Net Element’s strategy is to leverage its omni-channel platform to deliver flexible offerings to emerging markets with diverse banking, regulatory and demographic conditions. Net Element was ranked as one of the fastest growing companies in North America on Deloitte’s 2017 Technology Fast 500 ™ and South Florida Business Journal’s 2016 fastest growing technology companies.

Net Element believes the future of global commerce is being revolutionized as consumers quickly migrate toward omni-channel shopping utilizing mobile devices, desktop, and online services. Net Element’s all-in-one payment solutions support and unify a whole range of applications through a single, robust platform, allowing global onboarding and support for multiple payment methods.

With an eye on emerging markets, Net Element is pursuing growth opportunities and footholds in a number of industries. The company’s most recent application of its technology is to the cannabis industry, which is paced to hit $591 million and could increase 40 times in the next four years. This rampant growth also creates heightened need for smooth transactions between merchants and consumers. Payment processing and compliance for the cannabis industry has become increasingly complex, and Net Element’s Unified Payments subsidiary is addressing the challenges by offering a compliant, seamlessly integrated payment solution that makes it simple to transact.

Net Element has also launched a blockchain-focused business unit that will develop and deploy blockchain technology-based solutions. Net Element expects the new division to create a decentralized crypto-based ecosystem that will act as a framework for an unlimited number of value-added services, connecting merchants and consumers in a seamless, economically efficient transaction. This new business unit intends to also identify and invest in unique projects that decentralize and disrupt the payment processing industry by combining blockchain technology and real-world applications with talented development teams, strong fundamentals and addressable markets large in size.

“We believe that we’re at the dawn of a new evolution where additional digital payment methods are being introduced,” Net Element CEO Oleg Firer, says. “Introduction of our division focused on blockchain as part of the NASDAQ-listed entity will add transparency and compliance assurance to our investors as well as provide access to deploy value-added services to over 20 million electronic commerce clients that are currently part of Net Element’s growing network.”

Net Element clients are treated to customized solutions that provide the flexibility needed to keep up with customers. Among the services offered are mobile payment apps that accept payments anywhere, anytime; cloud-based solutions built to increase productivity and enhance revenue for clients and partners; marketing solutions that turn lookers into buyers; and business analytics that make it easy for clients to monitor business metrics, engage with customers and compare the competition. Its multi-channel platform combines e-commerce, offline, point-of-sale, comprehensive back office tools, mobile point-of-sale, credit scoring and customer interaction in one powerful platform-as-a-service technology.

Net Element owns and operates a global mobile payments and transactional processing provider, TOT Group, Inc., with the following subsidiaries:

  • Unified Payments – An award-winning, customized mobile billing and payments solution, recognized by Inc. Magazine as the No. 1 Fastest Growing Company in America in 2012.
  • Digital Provider – A leading provider of SMS messaging and mobile billing solutions.
  • Aptito – A next-generation, all-in-one, cloud-based restaurant management and point-of-sale payments platform using wireless technology.
  • Payonline – A fully integrated, processor agnostic electronic commerce platform.

Net Element is ranked No. 418 on Deloitte’s 2017 Technology Fast 500™ list of North America’s 500 fastest growing technology, media, telecommunications, life sciences and energy tech companies. Net Element grew 190 percent. The company’s chief executive officer, Oleg Firer, credits the company’s progression to organic growth in its North America Transactions Segment, specifically the success of its Unified Payments brand, which focuses on value-added payment acceptance solutions for small to medium enterprises in the United States.

“The Deloitte 2017 North America Technology Fast 500 winners underscore the impact of technological innovation and world class customer service in driving growth, in a fiercely competitive environment,” said Sandra Shirai, vice chairman, Deloitte Consulting LLP and U.S. technology, media and telecommunications leader. “These companies are on the cutting edge, and are transforming the way we do business.”

Net Element’s suite of application performing interfaces (APIs) and connectors power commerce for businesses of all sizes through multi-channel platforms, all-in-one digital solutions, and end-to-end encryption of cardholder data utilizing tamper resistant hardware that ensures integrity and simplifies security.

Net Element’s corporate team is led by director and CEO Oleg Firer, who is responsible for the overall vision, strategy and execution of the company’s mission of powering global commerce. He is joined by CFO Jeffrey Ginsburg, CPA, and Steven Wolberg, who is the company’s chief legal officer and secretary. Each corporate officer brings a unique blend of leadership, vision, experience and creative energy to the company.

From mobile payments and value-added transactional innovations such as Digital Provider and Aptito to e-commerce and retail payment transaction processing brands like Payonline and United Payments, Net Element is transforming the online and mobile experience.

Net Element (NETE), closed the day's trading session at $6.48, up 2.21%, on 165,043 volume with 765 trades. The average volume for the last 3 months is 323,718 and the stock's 52-week low/high is $3.75/$14.38.

Recent News

chart

FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF)

The QualityStocks Daily Newsletter would like to spotlight FinCanna Capital Corp. (FNNZF).

FinCanna Capital Corp. (CSE: CALI) a royalty company for the U.S. licensed medical cannabis industry is pleased to announce that further to its news release dated January 4, 2019 announcing an offering of $1.5 million of Secured Convertible Debentures (“Debentures”) the offering is being increased to $2.0 million due to over-subscriptions.

FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) is a royalty company aiming to be the capital partner of choice for high-growth, best-in-class businesses operating in the licensed U.S. medical cannabis industry. Primarily focused on the burgeoning California cannabis market, FinCanna leverages extensive investment expertise and industry experience to benefit its shareholders and portfolio companies.

Medical Cannabis Market

According to Ameri Research, the global market for licensed medical cannabis is growing at a compound annual growth rate (CAGR) of more than 21%, on track to exceed $63.5 billion by 2024. Within this market, FinCanna has identified considerable opportunity in California, the fifth largest economy in the world and the largest medical cannabis market in North America. Arcview Group forecasts California’s legal cannabis industry will grow at 21.1% CAGR to $6.5 billion in 2020, generating more than $1 billion in tax revenue.

Royalty Model & Portfolio

FinCanna’s “whole capital” solution for businesses in the licensed medical cannabis sector includes the provision of capital investment for a percentage of their future revenues. The FinCanna Capital Solution utilizes a royalty arrangement to deliver capital, in order to facilitate the growth or other specific objectives of its investees, and ensure the business opportunity is optimized. This model provides an alternative or complement to debt and equity financing, allowing investees to maintain financial flexibility and control of their business rather than entering into arrangements that may include restrictive debt structures or giving up an ownership stake.

FinCanna’s portfolio includes Cultivation Technologies, Inc. (“CTI”), a team of experts from Fortune 150 agriculture, medical cannabis, law, engineering and technology companies. FinCanna is providing funding to CTI for its planned, fully entitled, large-scale indoor medical cannabis facility to be developed in Coachella, California.

CTI has established an interim medical cannabis extraction facility (the “Interim Facility”) that will produce licensed medical cannabis products until the Coachella Project is complete. CTI is currently expanding its product line, Coachella Premium, to include vaporizer cartridges. Initial market feedback gathered during the product development phase indicates that Coachella Premium’s vaporizer cartridges offer a unique proposition within the vaporizer market, one of the fastest growing verticals in the cannabis market.

The Interim Facility can process up to 6,000 pounds of biomass per month, the equivalent of approximately 3.7 million grams of raw oil per year, with room for expansion. It is expected that the completed Coachella Project will be able to process 30,000 to 50,000 pounds of biomass per month, or the equivalent of 18 million grams to 30 million grams of raw oil per year.

Additionally FinCanna has entered into a royalty agreement with Green Compliance, a provider of point-of-sale software solution (“ezGreen”) for licensed medical cannabis dispensaries and cultivators. Green Compliance helps its customers comply with both the Health Insurance Portability and Accountability Act (“HIPAA”) and State Laws by ensuring patients’ confidential data is being handled properly, helping to protect from possible security breaches and financial and criminal liability resulting from potential violations.

FinCanna has also signed binding term sheet with Oakland, California-based Gram Co Holdings, subject to due diligence by FinCanna. Gram Co is a cannabinoid research and refinement facility focused providing B2B and B2C products and services to licensed medical dispensaries, infused product manufacturers, and numerous others in the cannabis supply chain. The company is also retrofitting a large, state-of-the-art medical cannabis extraction laboratory, which is expected to be operating in 2018.

The foregoing contains forward-looking statements regarding Cultivation Technologies Inc. (“CTI”) which are subject to risks, uncertainties and contingencies which include, but are not limited to the statements relating the future construction and completion of the CTI medical cannabis facility in Coachella, California, and the projected biomass processing and raw oil production at the facility. Such forward looking statements are based on assumptions regarding the construction, completion and operations of CTI’s proposed facility, including that CTI will obtain the financing required to build and equip its proposed facility, that CTI will obtain the additional financing required operate the facility, that construction facility is completed on time and budget, that CTI obtains state licenses to operate on a permanent basis, and that the equipment used in the cultivation of medical cannabis performs at scale in a similar way it performs at CTI’s pilot tests.

FinCanna Capital Corp. (FNNZF), closed the day's trading session at $0.0997, up 14.60%, on 120,919 volume with 28 trades. The average volume for the last 3 months is 52,644 and the stock's 52-week low/high is $0.0577/$0.8736.

Recent News

chart

SinglePoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight SinglePoint, Inc. (SING).

SinglePoint Inc. (OTCQB:SING) a fully reporting company is pleased to announce its investment in TorusMed Inc. to develop CBD Cell Cultures from industrial hemp. Recently the 2018 Farm Bill was passed, opening a vast array of opportunities. SinglePoint plans to quickly acquire and invest in companies dealing directly within the now legalized industrial hemp market. Also today, NetworkNewsWire released a report highlighting the company which examines how Congressional approval of the 2018 Federal Farm Bill that removes hemp production from federal prohibition is expected to create amazing new opportunities for industry representatives in 2019 and beyond.

SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.

SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.

SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:

  • A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
  • A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
  • A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
  • Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
  • Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
  • Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.

SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.

Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.

SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.

SinglePoint, Inc. (SING), closed the day's trading session at $0.02366, up 12.67%, on 10,716,118 volume with 487 trades. The average volume for the last 3 months is 5,930,788 and the stock's 52-week low/high is $0.0106/$0.0995.

Recent News

chart

VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF)

The QualityStocks Daily Newsletter would like to spotlight VIVO Cannabis Inc. (VVCIF).

VIVO Cannabis Inc. (TSX-V:VIVO, OTCQX: VVCIF) ("VIVO" or the "Company"), a licensed cannabis producer offering premium medical and adult-use products and services through its wholly-owned subsidiaries, ABcann Medicinals Inc. ("ABcann") and Canna Farms Ltd. ("Canna Farms"), today announce the appointment of Dr. Richa Love, MD, LMCC, CCFP, as the Company's Chief Medical Officer.

VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF) is a globally licensed, cost efficient producer of premium quality, organic, standardized medicinal cannabis. One of the earliest licensed medical marijuana producers under Canada’s federally-controlled Access to Cannabis for Medical Purposes Regulations (ACMPR), VIVO has five years of operating experience in the burgeoning medical marijuana space through its flagship operation, ABcann Medicinals, Inc. The company recently received its Health Canada license to produce medical cannabis oils and is working toward production of saleable, extracted, finished products that will lead to a final inspection allowing sales of its oils.

“Receipt of the license to produce cannabis oils is a major milestone in our pursuit to provide our medical cannabis patients with additional product formats that can be precisely dosed. The expansion and innovation of our product lines are a top priority for the Company as we continue to serve the needs of our customers, and we anticipate strong demand for our cannabis oil products,” VIVO CEO Barry Fishman said.

VIVO owns and operates a fully functioning 14,500 square foot facility in Napanee, Ontario, which is being doubled in size to produce 1,400 kg of cannabis per year. The company’s expansion plans include adding a seasonal greenhouse and a hybrid, multipurpose facility, capable of producing 31,000 kg of cannabis per year between the two facilities, to be constructed on 65 acres it already owns near the Napanee facility. This additional location is properly zoned with existing infrastructure in place for an eventual 1.2 million square feet of production space.

VIVO has built a reputation over the years for its best-in-class standardized approach to growing cannabis that includes the absence of pesticides and a computer monitored growing technique that provides a consistent, pharmaceutical-grade with high yields. The company’s custom, scalable growing chambers with proprietary lighting can be replicated anywhere in the world, leading to lower production costs. This technique has helped it record a customer retention rate of 94.7 percent alongside 30 percent month-over-month customer growth. When combined with VIVO’s current yield rate, which it has measured at roughly 100 percent greater than the industry average, the company has constructed a strong foundation upon which to build a sizable presence in the global cannabis industry.

This global growth potential is illustrated by VIVO’s partnership with Israel’s Syqe Medical, producer of the world’s first selective-dose pharmaceutical grade medicinal plant inhaler. After visiting VIVO’s production facility, Perry Davidson, founder of Syqe Medical, noted that the company’s production technologies put it “in a class with the best in the world” in its ability to produce standardized pharmaceutical grade cannabis.

VIVO’s recent acquisition of Harvest Medicine Inc. represents further progress toward the company’s goal of becoming a vertically integrated medical cannabis company. Harvest Medicine is one of the fastest growing medical cannabis clinics in Canada – adding over 1,200 new patients monthly from a single location – with an aggressive expansion plan and a patient-focused approach that perfectly aligns with VIVO’s philosophy of quality and innovation.

VIVO’s seasoned management team, board of directors and advisory board features well over a century of combined industry experience. Fishman, who has over 20 years of experience as a business leader, previously served as CEO of both Teva Canada and Taro Canada, as vice president of marketing at Eli Lilly Canada, and as past chair of the Canadian Generic Manufacturers Association. He most recently served as CEO of international specialty pharmaceutical company Merus Labs.

Notably, VIVO also has access to the ‘Father of Cannabis Research’, Raphael Mechoulam, PhD, through its board of advisors. An organic chemist and professor of medicinal chemistry at the Hebrew University of Jerusalem, Mechoulam was the first scientist to isolate both cannabidiol (CBD) and tetrahydrocannabinol (THC). He has received more than 25 prestigious academic awards, including the Rothschild Prize in Chemical Sciences and Physical Sciences in 2012.

With more than 65 acres of growth capacity, a healthy cash balance to fund upcoming construction efforts, steady sales growth, industry-leading yield rates and an established operations team in place, VIVO is well positioned to compete in the rapidly expanding Canadian cannabis industry and beyond.

VIVO Cannabis Inc. (VVCIF), closed the day's trading session at $0.6539, up 0.60%, on 654,995 volume with 292 trades. The average volume for the last 3 months is 387,321 and the stock's 52-week low/high is $0.413/$3.293.

Recent News

chart

Medical Cannabis Payment Solutions (REFG)

The QualityStocks Daily Newsletter would like to spotlight Medical Cannabis Payment Solutions (REFG).

With the recent passing of the Agriculture Improvement Act of 2018 in both the House of Representatives and the Senate legalizing of the production of hemp, Medical Cannabis Payment Solutions (OTC: REFG) is positioned at the forefront of the booming industry. To view the full article, visit: http://nnw.fm/9ZvZs.

Medical Cannabis Payment Solutions (REFG), headquartered in Cheyenne, Wyoming, is a first-tier merchant processing cannabis industry pioneer, offering one of the first and only comprehensive card processing operations of its kind to serve the state-sanctioned medical marijuana industry. The company’s state of the art system, which also tracks sales and tax collection, and eliminates the need to deal in cash-only transactions.

Through its robust, closed-loop merchant processing system, the company’s unique “StateSourced” proprietary system enables authorized operation under FinCEN parameters and complies with all regulatory frameworks. StateSourced is tailored to deliver full-spectrum merchant processing services, providing the convenience of modern commercial card processing resources and making it the first operation of its kind geared to the legal cannabis industry.

StateSourced is not a prepaid or gift card, which is an important variable for merchants since standard banking institutions have not offered this form of payment processing to the legal cannabis industry. Federal law still considers marijuana illegal under the Controlled Substances Act, although 29 states and the District of Columbia have legalized the plant either for medicinal or recreational uses or both. This restriction has kept financial institutions at bay since most banks are federally insured and haven’t been inclined to venture into the nascent industry.

Medical Cannabis Payment Solutions is able to offer its StateSourced card on a state-by-state basis where the card can be used in purchasing product from a legal, authorized vendor, providing a much-needed option for consumers and businesses alike. In another first, the company is collaborating with First Bitcoin Capital Corporation to integrate First Bitcoin’s cryptocurrency ($Weed) with Medical Cannabis Payment Solutions’ StateSourced payment gateway. This collaboration will allow state-licensed marijuana establishments across the nation to accept both StateSourced debit cards and cryptocurrencies such as WeedCoin and Bitcoin.

Medical Cannabis Payment Solutions president and CEO Jeremy Roberts and his executive team are working with state lawmakers to introduce legislation in an effort to address the growing problems in banking for the medical cannabis industry. For companies in the emerging legal cannabis industry, where retail and non-retail transactions such as vendor payments and payroll are almost exclusively paid for with cash, the solutions offered by StateSourced can help businesses avoid the inherent risks associated with a cash-intensive sector. Medical Cannabis Payment Solutions has also signed its first StateSourced contract with a Las Vegas-based vertically integrated marijuana establishment.

“We’ve completed our transition from development stage to revenue stage,” says Roberts. “We have just started our business development efforts and the market is responding very well. We anticipate having many more, similar releases.”

Medical Cannabis Payment Solutions provides end-to-end management across multiple systems for medicinal marijuana operations. The company solves the fragmentation problem experienced by many of these rapidly growing companies by identifying tools that are important to dispensaries and customizing those tools to meet the specific needs of this unique industry.

Medical Cannabis Payment Solutions (REFG), closed the day's trading session at $0.023, even for the day, on 551,940 volume with 38 trades. The average volume for the last 3 months is 429,481 and the stock's 52-week low/high is $0.0127/$0.079.

Recent News

chart

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)

The QualityStocks Daily Newsletter would like to spotlight The Green Organic Dutchman (OTC: TGODF).

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF) was highlighted today in a report by Financialnewsmedia.com explaining that, while Canadian hemp/CBD farming operations have had a head start on their U.S. counterparts, the 2018 Farm Bill which took effect on January 1, 2019, will give U.S. farming operations a much-needed boost.

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).

Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.

TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.

Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.

Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.

The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.

The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.

TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.

Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.

Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.

TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.

To learn more about the company and how to invest, contact TGOD directly at financing@tgod.ca

The Green Organic Dutchman (OTC: TGODF), closed the day's trading session at $1.92, off by 1.54%, on 854,876 volume with 1,018 trades. The average volume for the last 3 months is 1,034,640 and the stock's 52-week low/high is $1.607/$7.894.

Recent News

chart

ChineseInvestors.com (CIIX)

The QualityStocks Daily Newsletter would like to spotlight ChineseInvestors.com (CIIX).

ChineseInvestors.com (CIIX) was featured today in a report by CannabisNewsWire which examines how, as the year comes to an end, many investors are evaluating their portfolios and are planning how to reallocate funds from losing investments to other avenues where the earning potential is higher. If you plan to make money from the cannabis industry, read on and discover the three trends that you can consider as you make your 2019 investment allocations.

Founded in 1999, ChineseInvestors.com (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world’s first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer’s disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX’s cannabis-focused “Yelp”-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide.

ChineseInvestors.com (CIIX), closed the day's trading session at $0.492, off by 3.15%, on 115,194 volume with 69 trades. The average volume for the last 3 months is 260,704 and the stock's 52-week low/high is $0.365/$1.25.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.